Alteri Wealth LLC Makes New Investment in Agilent Technologies, Inc. (NYSE:A)

Alteri Wealth LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 37,786 shares of the medical research company's stock, valued at approximately $5,076,000. Agilent Technologies accounts for 1.4% of Alteri Wealth LLC's portfolio, making the stock its 12th largest position.

Other institutional investors have also recently made changes to their positions in the company. CKW Financial Group increased its stake in shares of Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock valued at $25,000 after purchasing an additional 100 shares in the last quarter. Global X Japan Co. Ltd. grew its stake in shares of Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after buying an additional 116 shares during the last quarter. Redwood Park Advisors LLC bought a new position in Agilent Technologies during the 4th quarter valued at approximately $27,000. Lee Danner & Bass Inc. bought a new position in Agilent Technologies during the 4th quarter valued at approximately $29,000. Finally, Hanson & Doremus Investment Management raised its stake in Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock valued at $35,000 after buying an additional 105 shares during the last quarter.

Insider Buying and Selling at Agilent Technologies

In related news, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the sale, the director now owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. This trade represents a 4.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Rodney Gonsalves sold 1,908 shares of the company's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now owns 21,786 shares of the company's stock, valued at $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Agilent Technologies Stock Up 2.1 %

Shares of A stock opened at $108.68 on Friday. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $155.35. The stock has a market cap of $30.98 billion, a P/E ratio of 24.98, a P/E/G ratio of 3.00 and a beta of 1.27. The company has a 50 day simple moving average of $113.57 and a two-hundred day simple moving average of $129.83.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, research analysts expect that Agilent Technologies, Inc. will post 5.54 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date of this dividend was Tuesday, April 1st. Agilent Technologies's payout ratio is 22.76%.

Wall Street Analyst Weigh In

A has been the topic of a number of recent analyst reports. TD Cowen increased their price target on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a report on Thursday, April 10th. Wells Fargo & Company cut their target price on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Robert W. Baird decreased their price target on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research note on Thursday, February 27th. Barclays dropped their price objective on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. Finally, Jefferies Financial Group decreased their target price on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Seven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $143.00.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.